US Patent Issued to QUORUM BIO on Oct. 6 for "Composition for prevention, amelioration, or treatment of hypersensitivity immune disease containing galactose" (South Korean Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,961, issued on Oct. 6, was assigned to QUORUM BIO Co. LTD. (Seoul, South Korea).

"Composition for prevention, amelioration, or treatment of hypersensitivity immune disease containing galactose" was invented by Hye Eun Kim (Seoul, South Korea), Eunju Ryu (Seoul, South Korea), Jae Hyun Sim (Seoul, South Korea) and Jun Sim (Incheon, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to use for the prevention and/or alleviation and/or treatment of hypersensitivity immune disease, containing galactose and, more particularly, provides a pharmaceutical composition and a health functional food that comprise galactose for...